Skip to content

Neuroplasticity: all studies

Page 111 of 178: studies 1,101 to 1,110 of 1,772, newest first. Back to the neuroplasticity overview

Research

SUPPLEMENTING WITH DEXTROMETHORPHAN MAY ENHANCE COGNITIVE FUNCTIONS IN YOUNG INDIVIDUALS WITH BIPOLAR DISORDERS

The International Journal of Neuropsychopharmacology February 1, 2025 Chih-Chun Huang, Y. Chang, Ru-Band Lu et al.

Abstract Background Bipolar disorder (BD) is a chronic, debilitating mental condition with consistent prevalence across genders and ethnicities. It's marked by high relapse rates, mood swings, and disruptions in various life aspects. Prior research has highlighted neuropsychological impairments in BD. Aims & Objectives This study investigates the therapeutic effect of dextromethorphan (DM), an...

Delay Coordinate Embedding as Neuronally Implemented Information Processing: The State Space Theory of Consciousness

Journal of Consciousness Studies February 1, 2025 V. O’Reilly-Shah

This paper introduces the state space theory of consciousness, positing that the cortex processes information through delay coordinate embedding operationalized by recurrent neural network engines. This leverages the power of Takens' theorem, giving rise to representations of reality as points within state space. Consciousness is posited to arise at the highest order engines amongst...

BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL

The International Journal of Neuropsychopharmacology February 1, 2025 Leonard Lerer, Kathleen Spear, Jeet Varia et al.

Abstract Background Psilocybin research in depression has been generated using chemically synthesized psilocybin (PSI). Psychedelic mushrooms produce additional tryptamines that may enhance the neuroplastic effect of psilocybin. In a rodent depression model, an extract of a psychedelic mushroom (PME) had a stronger and more prolonged effect than PSI on behavior[1]. Aims and Objectives To...

DOI: 10.1093/ijnp/pyae059.254 (opens in new tab) Psilocybin Zebrafish Hallucinogen Depression economics +5

Psychedelics and schizophrenia: a double-edged sword.

Molecular Psychiatry February 1, 2025 Jacopo Sapienza, Francesca Martini, Stefano Comai et al. 11 citations

Psychedelics have shown promising effects in several psychiatric diseases as demonstrated by multiple clinical trials. However, no clinical experiments on patients with schizophrenia have been conducted up to date, except for some old semi-anecdotal studies mainly performed in the time-span '50s-'60s. Notably, these studies reported interesting findings, particularly on the improvement of...

DOI: 10.1038/s41380-024-02743-x (opens in new tab) Full text (opens in new tab) Schizophrenia treatment Mental health research Psychedelics Psychiatric medicine

Psychedelics in neuroinflammation: Mechanisms and therapeutic potential

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 31, 2025 Júnia L. de Deus, Juliana Marino Maia, Renato Nery Soriano et al. 27 citations

Neuroinflammation is a critical factor in the pathogenesis of various neurodegenerative and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and major depressive disorder. Psychedelics, such as psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT), have demonstrated promising therapeutic effects on neuroinflammation, primarily through interactions...

Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications

Pharmaceuticals January 19, 2025 Marco Bonaso, Letizia Biso, Benedetta Zucchini et al. 13 citations

Psychedelics, historically celebrated for their cultural and spiritual significance, have emerged as potential breakthrough therapeutic agents due to their profound effects on consciousness, emotional processing, mood, and neural plasticity. This review explores the mechanisms underlying psychedelics’ effects, focusing on their ability to modulate brain connectivity and neural circuit activity,...

Persistent large-scale changes in alternative splicing in prefrontal cortical neuron types following psychedelic exposure.

bioRxiv : the preprint server for biology January 16, 2025 Yungyi Hsiao, Marcos As Fonseca, Alina S Tiemroth et al. preprint

Psychedelics engage the serotonergic system as potent neuromodulators, increasing neuroplasticity in humans and rodents. Persistent changes in cognitive flexibility, emotional regulation, and social cognition are thought to underlie the therapeutic effects of psychedelics. However, the underlying molecular and cellular basis of psychedelic-induced plasticity remains unclear. Here, we identify...

Applications of MDMA in Modern Medicine - A Literature Review

Journal of Education, Health and Sport January 14, 2025 Wiktoria Podlasiewicz, Paweł Siudziński, Mateusz Łyko et al.

MDMA or 3,4- methylenedioxymethamphetamine is a psychoactive substance, exhibiting mild hallucinogenic properties, that became widely known as a recreational party drug. However, its ability in helping individuals access deeply rooted emotions has prompted significant interest in its potential applications within clinical practice. MDMA’s mechanism of action involves increasing the release of...

DOI: 10.12775/jehs.2025.77.56620 (opens in new tab) MDMA Traditional medicine Pharmacology

Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases.

Scientific Reports January 13, 2025 Fikret Sahin, Aslihan Gunel, Buse Turegun Atasoy et al. 10 citations

NMDAR antagonists, such as memantine and ketamine, have shown efficacy in treating neurodegenerative diseases and major depression. The mechanism by which these drugs correct the aforementioned diseases is still unknown. Our study reveals that these antagonists significantly enhance 20S proteasome activity, crucial for degrading intrinsically disordered, oxidatively damaged, or misfolded...

DOI: 10.1038/s41598-024-84479-w (opens in new tab) Full text (opens in new tab) Mental diseases N-methyl-d-aspartate receptor nmdar antagonists Neurodegenerative diseases Proteasome +5

Exploring The Role of Yoga in Promoting Mental Well – Being and Emotional Resilience

INTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT January 10, 2025 S. Saurabh

This essay examines how yoga, as a holistic practice, can improve mental health and build emotional fortitude. The study explores how yoga incorporates physical postures, breathwork, and mindfulness to alleviate stress, anxiety, and emotional difficulties, drawing on scientific research and traditional traditions. It looks at the psychological and physiological processes—such as autonomic...